Skip to content. | Skip to navigation

Personal tools
You are here: Home topics Pharmaceuticals
Document Actions

Pharmaceuticals Policy in the EU

Latest news on the pharmaceutical policies of the European Union.

Proposal to ensure continued supply of medicines to Northern Ireland, as well as Cyprus, Ireland and Malta 12 April 2022, 23:35 CET
The EU Council adopted on 12 April proposals to ensure the continued long-term supply of medicines from Great Britain to Northern Ireland and to address outstanding supply concerns in Cyprus, Ireland and Malta.

Europe builds preparedness against potential health threats 08 April 2022, 17:39 CET
The EU moved Wednesday to bolster its capacity to respond to public health risks with a decontamination reserve and a new stockpile of equipment tailored to chemical, biological or nuclear emergencies.

EU looks to tighten vaccine export controls 25 March 2021, 20:52 CET
The European Commission introduced new, tougher criteria of 'reciprocity and proportionality' Wednesday under its transparency and authorisation mechanism for COVID-19 vaccine exports.

Brussels extends export controls for COVID-19 vaccines 11 March 2021, 23:09 CET
As Europe continues to suffer delays in some deliveries of vaccines, the EU Commission extended Thursday its 'transparency and authorisation' mechanism for COVID-19 vaccine exports to end June.

4m doses of BioNTech-Pfizer vaccine for EU's coronavirus hotspots 10 March 2021, 22:15 CET
The EU Commission reached an agreement with BioNTech-Pfizer Wednesday for the supply of four million more doses of COVID-19 vaccines for Member States in order to tackle coronavirus hotspots.

EU agency needs to be more open in pandemic response: Ombudsman 10 February 2021, 21:05 CET
The EU Ombudsman called Tuesday for greater transparency and public scrutiny at Europe's disease prevention agency, as part of a wide-ranging enquiry into how EU institutions responded to the pandemic.

New EU pharma strategy to make medicines affordable 26 November 2020, 17:21 CET
A new pharmaceutical strategy, adopted Wednesday by the EU Commission, offers patients access to affordable medicines and supports competitiveness and innovation in Europe's pharma industry.

A Pharmaceutical Strategy for Europe - guide 25 November 2020, 16:49 CET
The European Commission adopted on 25 November a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU's pharmaceutical industry.

EU approves BioNTech -Pfizer contract for access to vaccine 12 November 2020, 17:01 CET
The Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer Wednesday, providing for an initial purchase of 200 million doses on behalf of all EU Member States.

Brussels signs first contract with AstraZeneca 31 August 2020, 23:58 CET
The first pharmaceutical contract negotiated by the EU Commission on behalf of EU Member States entered into force Thursday following the formal signature between AstraZeneca and the Commission.

Brussels concludes talks with fifth vaccine manufacturer 25 August 2020, 00:25 CET
The EU concluded exploratory talks with U.S. based company Moderna Monday to purchase a potential vaccine against COVID-19 - the fifth company with which the Commission has concluded talks.

New talks with CureVac expand EU portfolio of future vaccines 20 August 2020, 23:59 CET
The EU Commission concluded Thursday exploratory talks with CureVac to purchase a potential vaccine against COVID-19, offering the possibility for all EU Member States to purchase the vaccine.

European Vaccines Strategy 20 August 2020, 23:54 CET
As part of the effort to help protect people everywhere and EU citizens in particular, the Commission is proposing an EU strategy to accelerate the development, manufacturing, and deployment of vaccines against COVID-19. COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE EUROPEAN COUNCIL, THE COUNCIL AND THE EUROPEAN INVESTMENT BANK EU Strategy for COVID-19 vaccines - COM/2020/245 final

Brussels reaches 1st agreement on potential COVID-19 vaccine 19 August 2020, 00:11 CET
The Commission reached first agreement Friday with pharmaceutical company AstraZeneca to buy a potential vaccine against COVID-19 as well as to donate to lower and middle income countries.

Brussels secures EU access to COVID-19 drug Remdesivir 31 July 2020, 18:45 CET
The European Commission signed a contract with pharmaceutical company Gilead Tuesday to secure treatment doses of Veklury, the brand name for Remdesivir, for EU Member States and the UK.

First Ebola vaccine receives European approval 13 November 2019, 00:01 CET
The European Commission adopted a decision Tuesday granting the first-ever market authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against the deadly Ebola virus.

EU, US agree pharmaceuticals mutual recognition 17 July 2019, 15:56 CET
The EU and the United States have completed a Mutual Recognition Agreement, with both sides agreeing to reduce barriers and increase trade in pharmaceuticals as part of ongoing EU-U.S. trade talks.

EU launches ICT, pharma cases against India, Turkey at WTO 02 April 2019, 22:26 CET
The EU brought two disputes in the World Trade Organisation against India and Turkey Tuesday, respectively targeting unlawful import duties on IT products and unlawful measures on pharmaceuticals.

Drug use increase in European cities: wastewater report 14 March 2019, 14:23 CET
The latest findings from the largest European project in the emerging science of wastewater analysis were presented Thursday by the Europe-wide SCORE group, in association with the EU drugs agency.

Strategic approach to pharmaceuticals in the environment 13 March 2019, 15:57 CET
The European Commission adopted on 11 March a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment.

New EU rules on fake drugs enter into force 12 February 2019, 19:07 CET
New rules on safety features for prescription medicines sold in the EU entered into force Saturday, heralding the introduction of end-to-end verification and safety features on prescription medicines.

Falsified medicines 11 February 2019, 14:14 CET
Falsified medicines are often disguised as authentic medicines but may contain ingredients of bad or toxic quality, or in the wrong dosage. As they have not been properly checked for quality, safety and efficacy, as required by strict EU authorisation, they can pose a real risk to your health. As falsified medicines become more sophisticated, the risk of them reaching patients in the EU increases. They represent a serious threat to global health and call for a comprehensive strategy both at European and international level.

New safety features for medicines sold in the EU 11 February 2019, 14:16 CET
As of 9 February 2019, the new rules on safety features for prescription medicines sold in the EU will apply.

Boost for joint European assessment of medicines 04 October 2018, 18:23 CET
A new law adopted by the European Parliament on Wednesday aims to avoid duplicating national assessments to determine a medicine's added value that help EU countries decide on pricing.

Drugs report highlights resurgence of cocaine in Europe 08 June 2018, 00:11 CET
The European Drug Report 2018, issued by the EU drugs agency Thursday, highlights increased availability of cocaine in Europe, with around 2.3 million young adults having used the drug in the last year.